Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study

Archive ouverte

Plebani, Mario | Parčina, Marijo | Bechri, Issam | Zehender, Gianguglielmo | Terkeš, Vedrana | Abdel Hafith, Balqis | Antinori, Spinello | Pillet, Sylvie | Gonzalo, Sylvie | Hoerauf, Achim | Lai, Alessia | Morović, Miro | Bourlet, Thomas | Torre, Alessandro | Pozzetto, Bruno | Galli, Massimo

Edité par CCSD ; American Society for Microbiology -

International audience. This study assessed the diagnostic performance of the new coronavirus disease 2019 (COVID-19) SEROSpeed IgM/IgG Rapid Test (BioSpeedia, a spinoff of the Pasteur Institute of Paris) for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in comparison to other commercial antibody assays through a large cross-European investigation. The clinical specificity was assessed on 215 prepandemic sera (including some from patients with viral infections or autoimmune disorders).

Consulter en ligne

Suggestions

Du même auteur

Evaluation of Rapid Lateral-Flow Tests Directed against the SARS-CoV-2 Nucleoprotein Using Viral Suspensions Belonging to Different Lineages of SARS-CoV-2

Archive ouverte | Pillet, Sylvie | CCSD

International audience. Within the successive waves that occurred during the SARS-CoV-2 pandemic, recommendations arose to test symptomatic and contact subjects by using rapid antigen devices directed against the vi...

SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.

Archive ouverte | Gagnaire, Julie | CCSD

International audience. No abstract available

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Archive ouverte | Legros, Vincent | CCSD

International audience. Understanding the immune responses elicited by SARS-CoV-2 infection is critical in terms of protection against reinfection and, thus, for public health policy and vaccine development for COVI...

Chargement des enrichissements...